For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240426:nRSZ2632Ma&default-theme=true
RNS Number : 2632M Savills PLC 26 April 2024
SAVILLS PLC (THE "COMPANY")
TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)
Vesting of Share Awards
Awards over ordinary shares of the Company under the Deferred Share Plan have
become unconditional in all respects following the end of their Deferred
Period. In satisfaction of the Awards, the Trustee of the Savills US
Employee Benefit Trust effected the transfer of shares, following the
settlement of associated tax liabilities through the sale of shares, to a PDMR
of the Company based in North America as follows:-
PDMR Number of Shares Transferred Number of Shares Disposed Shareholding following this notification Shareholding as a % of issued share capital
David Lipson 39,058 19,488 103,699 0.07%
The share price on disposal of shares was £10.45 per share.
Grant of Share Awards
The Company announces that on 24 April 2024 the grant of the share-based
element of 2023 profit share awards has been made under the Savills Deferred
Share Bonus Plan to Directors and PDMRs as follows:-
Director/ PDMR Number of shares subject to the Savills Deferred Share Bonus Plan awarded to
the Director/ PDMR on 24 April 2024
Mark Ridley (Director) 58,841
Simon Shaw (Director) 45,105
Alex Jeffrey (PDMR) 18,234
Chris Lee (PDMR) 9,596
Raymond Lee (PDMR) 41,266
David Lipson (PDMR) 7,712
Christian Mancini (PDMR) 7,869
James Sparrow (PDMR) 33,589
These awards have a Deferred Period of three years and are subject to
rolled-up dividend shares whereby the number of shares awarded will be
increased on the vesting date to reflect final and interim dividends declared
during the Deferred Period.
The Company announces that on 24 April 2024 the grant of an award has been
made under The Schedule to The Savills Deferred Share Plan to a PDMR based in
the United States of America as follows:-
PDMR Number of shares subject to the Savills Deferred Share Plan awarded to the
PDMR on 24 April 2024
David Lipson (PDMR) 38,563
One-third of Mr Lipson's award will vest on each of the three anniversaries
subsequent to the date of grant subject to continued employment and
performance. The award is subject to rolled-up dividend shares whereby the
number of shares awarded will be increased on the vesting dates to reflect
final and interim dividends declared during the Deferred Periods.
Resulting beneficial interests under the Savills Deferred Share Bonus Plan and
Savills Deferred Share Plan further to the above notifications are as follows:
Director/ PDMR Resulting beneficial interest under the Savills Deferred Share Bonus Plan and
Savills Deferred Share Plan
Mark Ridley (Director) 281,493
Simon Shaw (Director) 214,056
Alex Jeffrey (PDMR) 307,184
Chris Lee (PDMR) 74,917
Raymond Lee (PDMR) 171,840
David Lipson (PDMR) 151,801
Christian Mancini (PDMR) 146,303
James Sparrow (PDMR) 163,057
The information set out below is provided in accordance with the requirements
of Article 19 of the EU Market Abuse Regulation No 596/2014.
1. Details of the Director/ PDMR
(a) Name 1. Mark Ridley
2. Simon Shaw
3. Alex Jeffrey
4. Chris Lee
5. Raymond Lee
6. David Lipson
7. Christian Mancini
8. James Sparrow
2. Reason for the notification
(a) Position/ status 1. Group Chief Executive/ Director
2. Group Chief Financial Officer/ Director
3. Chief Executive Officer - Savills Investment Management/ PDMR
4. Group Legal Director and Company Secretary/ PDMR
5. Chief Executive - Hong Kong, Macau and Greater China/ PDMR
6. Chief Executive Officer - Savills North America/ PDMR
7. Chief Executive Officer - Asia Pacific (ex-Greater China)/ PDMR
8. Chief Executive Officer, UK & CEME/ PDMR
(b) Initial notification/ Amendment Initial notification
3. Details of the issuer
(a) Name Savills plc
(b) LEI 213800WXICGMBWHTA933
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
(a) Description of the Financial Instrument Savills plc Ordinary Shares of 2.5p each
(b) Identification code of the Financial Instrument GB00B135BJ46
(c) Nature of the transaction 1) Vesting of awards under the Company's Deferred Share Plan and sale of
shares to satisfy associated tax liabilities
2) Grant of awards over Ordinary Shares in accordance with the Company's
Deferred Share Bonus Plan and Deferred Share Plan
(d) Price(s) and volume(s) Price(s) Volume(s)
1) 1. n/a
Acquisition 2. n/a
£nil per share 3. n/a
4. n/a
5. n/a
6. 39,058
7. n/a
8. n/a
9. n/a
Disposal 1. n/a
£10.45 per share 2. n/a
3. n/a
4. n/a
5. n/a
6. 19,488
7. n/a
8. n/a
9. n/a
2) 1. 58,541
£nil per share 2. 45,105
3. 18,234
4. 9,596
5. 41,266
6. 46,275
7. 7,869
8. 33,589
(e) Aggregated information N/A
- Aggregated volume
- Price
(f) Date of the transaction 24 April 2024
(g) Place of the transaction Outside a trading venue
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
26 April 2024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHMZGZDFVMGDZM